Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-01-01 @ 8:14 PM
Study NCT ID:
NCT00941603
Status:
COMPLETED
Last Update Posted:
2018-09-25
First Post:
2009-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2010-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-16
First Submit QC Date:
None
Study First Post Date:
2009-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-14
Results First Submit QC Date:
None
Results First Post Date:
2016-04-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-04-15
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-08-27
Last Update Post Date:
2018-09-25
Last Update Post Date Type:
ACTUAL